Home › Atrial Fibrillation › South Carolina
Atrial Fibrillation clinical trials in South Carolina
8 studies for Atrial Fibrillation are looking for participants at sites in South Carolina.
Cities in South Carolina
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- Medical University of South Carolina, Charleston
- MUSC Health Heart and Vascular, Columbia
RecruitingPhase 3
Ages 22 to 85 · All sexes · Updated Sep 30, 2026 · NCT05836987Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
- Trident Medical Center, Charleston
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07575269Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Upstate Cardiology, Greenville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071PULSED AF Post-Approval Study
- AnMed Health Center, Anderson
- Medical University of South Carolina (MUSC), Charleston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06578104Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- AnMed Health, Anderson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Trident Medical Center, Charleston
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 15, 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigational site 9814, Fort Mill
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Medical University of South Carolina University Hospital, Charleston
- Greenville Hospital System, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.